Sulfamethoxazole CAS:723-46-6

Sulfamethoxazole, in combination with trimethoprim, is used to treat various bacterial infections, including urinary tract infections, respiratory tract infections, gastrointestinal infections, skin and soft tissue infections, and certain sexually transmitted infections. This combination therapy is particularly effective against bacteria such as Escherichia coli, Staphylococcus aureus, and Pneumocystis jirovecii. Co-trimoxazole is available in oral formulations such as tablets and suspension, allowing for convenient administration in both outpatient and inpatient settings. The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient's age, weight, and renal function. It is essential to follow the prescribed dosage regimen and complete the full course of treatment to ensure successful eradication of the bacterial infection and reduce the risk of antibiotic resistance. Patients should be aware of potential side effects associated with sulfamethoxazole-trimethoprim therapy, including gastrointestinal disturbances, allergic reactions, and rare but serious adverse effects such as Stevens-Johnson syndrome and hematological abnormalities. Monitoring for adverse reactions and consulting healthcare providers for guidance on appropriate use and management of side effects are crucial for safe and effective treatment with sulfamethoxazole-containing medications.